Oncology Companion Diagnostics Market Size & Share Report 2033

Research Methodology – Oncology Companion Diagnostics Market

At Straits Research, we adopt a rigorous 360° research approach that integrates both primary and secondary research methodologies. This ensures accuracy, reliability, and actionable insights for stakeholders. Our methodology for the Oncology Companion Diagnostics Market comprises the following key stages:

Market Indicator & Macro-Factor Analysis

Our baseline thesis for the Oncology Companion Diagnostics Market is developed by integrating key market indicators and macroeconomic variables. These include:

1 Factors considered while calculating market size and share

Number of patients diagnosed and treated for cancer on a global, regional, and local scale
Demand and usage of companion diagnostics in oncology healthcare and research facilities
Market penetration of personalized cancer therapy
Regulatory guidelines and approval processes for oncology companion diagnostics
Technological advancements in oncology companion diagnostic methods
Healthcare expenditure and insurance coverage on a world, regional, and national level
Pricing and Costing factors of oncology companion diagnostics
Level of competition and key players in the oncology companion diagnostics market

2 Key Market Indicators

Prevalence and Incidence rate of various types of cancer worldwide and in specific regions
Approval and Launch of new Oncology Companion Diagnostics Products
Investment in Research and Development activities related to Oncology Companion Diagnostics
Adoption rate of Oncology Companion Diagnostics in healthcare setups
Strategic alliances, mergers, acquisitions, and partnerships in the oncology companion diagnostics market
Patent Expiry dates of key Oncology Companion Diagnostics products.

3 Growth Trends

Increased preference for personalized and target-based oncology treatments
Increasing partnerships between biopharmaceutical companies and diagnostic service providers
Rapid advancements in Genomics and Proteomics contributing to the growth of the market
Growing investments in cancer research driving the demand for Oncology Companion Diagnostics
Government initiatives and Grants for promoting precision medicine
Growth of Biomedical Imaging and Bioinformatics in Oncology Companion Diagnostics

Secondary Research

Our secondary research forms the foundation of market understanding and scope definition. We collect and analyze information from multiple reliable sources to map the overall ecosystem of the Oncology Companion Diagnostics Market. Key inputs include:

Company-Level Information

Annual reports, investor presentations, SEC filings
Company press releases and product launch announcements
Public executive interviews and earnings calls
Strategy briefings and M&A updates

Industry and Government Sources

Country-level industry associations and trade bodies
Government dossiers, policy frameworks, and official releases
Whitepapers, working papers, and public R&D initiatives
Relevant Associations for the Oncology Companion Diagnostics Market

Market Intelligence Sources

Broker reports and financial analyst coverage
Paid databases (Hoovers, Factiva, Refinitiv, Reuters, Statista, etc.)
Import/export trade data and tariff databases
Sector-specific journals, magazines, and news portals

Macro & Consumer Insights

Global macroeconomic indicators and their cascading effect on the industry
Demand–supply outlook and value chain analysis
Consumer behaviour, adoption rates, and commercialization trends

Primary Research

To validate and enrich our secondary findings, we conduct extensive primary research with industry stakeholders across the value chain. This ensures we capture both qualitative insights and quantitative validation. Our primary research includes:

Expert Insights & KOL Engagements

Key Opinion Leader (KOL) Engagements
Structured interviews with executives, product managers, and domain experts
Paid and barter-based interviews across manufacturers, distributors, and end-users

Focused Discussions & Panels

Discussions with stakeholders to validate demand-supply gaps
Group discussions on emerging technologies, regulatory shifts, and adoption barriers

Data Validation & Business POV

Cross-verification of market sizing and forecasts with industry insiders
Capturing business perspectives on growth opportunities and restraints

Data Triangulation & Forecasting

The final step of our research involves data triangulation ensuring accuracy through cross-verification of:

Demand-side analysis (consumption patterns, adoption trends, customer spending)
Supply-side analysis (production, capacity, distribution, and market availability)
Macroeconomic & microeconomic impact factors

Forecasting is carried out using proprietary models that combine: